NVNO · Categories · Form 4

NVNO - SEC Form 4 insider transactions

enVVeno Medical Corporation (NVNO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NVNO

• 88d
  Director Duhay Francis sold $1,613 worth of shares (140 units at $11.52), decreasing direct ownership by 5% to 2,502 units (SEC Form 4)

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 173d
  SEC Form 4 filed by Chief Executive Officer Berman Robert Andrew

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 173d
  SEC Form 4 filed by Chief Technology Officer Alavi Hamed

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 173d
  SEC Form 4 filed by SVP & Chief Medical Officer Glickman Marc H.

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 176d
  SEC Form 4 filed by Director Duhay Francis

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 176d
  SEC Form 4 filed by Director Gray Robert

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 176d
  SEC Form 4 filed by Director Jenusaitis Matthew

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 176d
  SEC Form 4 filed by Director Shrivastava Sanjay

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 179d
  Director Duhay Francis sold $1,742 worth of shares (4,900 units at $0.36), decreasing direct ownership by 5% to 92,544 units (SEC Form 4)

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 265d
  Director Duhay Francis sold $4,067 worth of shares (4,900 units at $0.83), decreasing direct ownership by 5% to 97,444 units (SEC Form 4)

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 385d
  SEC Form 4 filed by Chief Financial Officer Bright Jennifer

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 536d
  SEC Form 4 filed by Chief Technology Officer Alavi Hamed

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 536d
  SEC Form 4 filed by SVP & Chief Medical Officer Glickman Marc H.

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 536d
  SEC Form 4 filed by Director Gray Robert

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 536d
  SEC Form 4 filed by Director Shrivastava Sanjay

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 536d
  SEC Form 4 filed by Chief Executive Officer Berman Robert Andrew

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 536d
  SEC Form 4 filed by Director Jenusaitis Matthew

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 536d
  SEC Form 4 filed by Director Duhay Francis

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 816d
  Alavi Hamed sold $51,837 worth of shares (8,334 units at $6.22) and exercised 8,334 shares at a strike of $3.59 (SEC Form 4)

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 915d
  SEC Form 4 filed by Glynn Craig

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 915d
  SEC Form 4 filed by Alavi Hamed

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 915d
  SEC Form 4 filed by Gray Robert

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 915d
  SEC Form 4 filed by Jenusaitis Matthew

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 915d
  SEC Form 4 filed by Duhay Francis

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 915d
  SEC Form 4 filed by Shrivastava Sanjay

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 915d
  SEC Form 4 filed by Glickman Marc H.

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 915d
  SEC Form 4 filed by Berman Robert Andrew

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1285d
  SEC Form 4 filed by Gray Robert

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1285d
  SEC Form 4 filed by Jenusaitis Matthew

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1285d
  SEC Form 4 filed by Shrivastava Sanjay

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1285d
  SEC Form 4 filed by Duhay Francis

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1362d
  SEC Form 4: Jenusaitis Matthew converted options into 1,041 shares, increasing direct ownership by 18% to 6,925 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1362d
  SEC Form 4: Gray Robert converted options into 1,041 shares, increasing direct ownership by 16% to 7,655 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1391d
  SEC Form 4: Duhay Francis bought $47,591 worth of shares (7,751 units at $6.14), increasing direct ownership by 59% to 20,911 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1439d
  SEC Form 4: Shrivastava Sanjay bought $3,850 worth of shares (1,000 units at $3.85), increasing direct ownership by 35% to 3,888 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1442d
  SEC Form 4: Berman Robert Andrew bought $9,500 worth of shares (2,500 units at $3.80), increasing direct ownership by 1% to 210,236 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1650d
  SEC Form 4: Berman Robert Andrew was granted 200,000 shares, increasing direct ownership by 2,585% to 207,736 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1650d
  SEC Form 4: Glickman Marc H. was granted 100,000 shares, increasing direct ownership by 6,250% to 101,600 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1650d
  SEC Form 4: Glynn Craig was granted 50,000 shares

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1663d
  SEC Form 4: Berman Robert Andrew bought $14,860 worth of shares (2,000 units at $7.43), increasing direct ownership by 35% to 7,736 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1664d
  SEC Form 4: Shrivastava Sanjay converted options into 388 shares, increasing direct ownership by 16% to 2,888 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)
• 1664d
  SEC Form 4: Berman Robert Andrew bought $15,740 worth of shares (2,000 units at $7.87), increasing direct ownership by 54% to 5,736 units

  4 - enVVeno Medical Corp (0001661053) (Issuer)

Other NVNO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends